News Artera gets FDA okay for prostate cancer AI A newly approved AI from Artera can guide treatment and predict prognosis in people diagnosed with localised prostate cancer.
Digital How GenAI will transform life sciences in 2025 The life sciences industry is in a position to help humanity, perhaps more than ever, with the introduction of generative AI (GenAI).
News Chiesi signs $1.9bn deal to buy KalVista and its HAE drug Chiesi has boosted its rare disease business with an agreement to buy KalVista and Ekterly, its oral drug for treating attacks in rare disease HAE.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
